The Medicines Patent Pool and Pharco Pharmaceuticals Sign Licence for Promising Hepatitis C Drug Candidate Ravidasvir
Fairly Used 2017-06-22
Summary:
Agreement seeks to improve health options for hepatitis C patients in low- and middle-income countries [Medicines Patent Pool Press Release, Link] Amsterdam, Netherlands, 21 April 2017 —The Medicines Patent Pool (MPP) announced a new licence and technology transfer agreement with Egyptian company Pharco Pharmaceuticals for ravidasvir (RAV), an investigational direct-acting antiviral (DAA) with the [...]